Unique Perspectives on the Cost Burden of Diabetes in the

United States

Panelists

NHANES Study: A1C Control

US Population ≥18 with End-Stage Renal Disease From T2D

Visual Impairment Related to T2D

Diabetes Cost

Projecting the Future Diabetes Population: The Imperative for

Change

Diabetes Prescription Drug Therapy Class Review

Cost-Effective Interventions

Incidence of T2D

Cost-Effectiveness of Lifestyle Modification or Metformin: DPP

Medication for Pre-T2D

YMCA Model of DPP in the Community

Measured Risk Factors for Teens

Measured Risk Factors Identified

Look AHEAD Trial

Trials of More vs Less Glucose Lowering

(All used more/earlier insulin vs less/later insulin)

Medication Adherence

Have the Conversation

Key Resources to Share With Your Patients

Take Home Points: Summary

Abbreviations

References

References (cont)

References (cont)